Alyacen 1/35 recalls
Alyacen 1/35 products have been recalled 1 time, most recently on 24 Jun 2026. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is potency & assay.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 24 Jun 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why alyacen 1/35 is recalled
Companies
Product types
By year
Ongoing alyacen 1/35 recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Alyacen 7/7/7, Norethindrone recalled by Glenmark PharmaceuticalsAlyacen 1/35 | Glenmark Pharmaceuticals Inc., USA | Potency & Assay | Nationwide |
All alyacen 1/35 recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Alyacen 7/7/7, Norethindrone recalled by Glenmark PharmaceuticalsAlyacen 1/35 | Glenmark Pharmaceuticals Inc., USA | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.